ABSOLUTELY CORRECT!
We manage the 70% AFTER the kids have been poisoned!!
Which is why remestemcel-L should be the front line and will be the first and the prophylactic therapy after bone marrow transplant and which replaces those awful treatments, like steroids. (I've said this many times but it doesn't get picked up.)
Which is why the colossal pushback because they will lose market share. This is what I mean by vested interests. Some of them are on the FDA decision making boards. As was the case with the advisory board that voted 9-1 in favour of approval. So who was the stand out? A person with a conflict of interest, then the decision went against. WHY?
It's unbelievable the remorseless pummelling that goes on here with respect to the truth.
At some point these cash for commenters are going to hold up and go:
this isn't worth it, I can't live with myself any longer.
And quietly up stumps.
There has to be a human heart deep in there. Has to be.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-17045
-
- There are more pages in this discussion • 776 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8683 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1335 | 1.160 |
1 | 8683 | 1.155 |
7 | 295447 | 1.150 |
3 | 70786 | 1.145 |
6 | 196386 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 32999 | 1 |
1.170 | 62618 | 6 |
1.175 | 48590 | 3 |
1.180 | 79079 | 4 |
1.185 | 17090 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online